Current Report Filing (8-k)
June 19 2018 - 04:31PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
June 13, 2018
SanSal
Wellness Holdings, Inc.
|
(Exact
name of registrant as specified in charter)
|
Nevada
|
|
333-191251
|
|
99-0375676
|
(State
or other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer
Identification No.)
|
6610
North University Drive #220, Fort Lauderdale, FL
|
|
33321
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: (
954) 722-1300
|
(Former
name or former address, if changed since last report)
|
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of Company under
any of the following provisions:
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting
material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
As
used in this Current Report on Form 8-K, and unless otherwise indicated, the terms “
the Company
,” “
SanSal
,”
“
we
,” “
us
” and “
our
” refer to SanSal Wellness Holdings, Inc. and its
subsidiary.
|
Item
3.02
|
Unregistered
Sales of Equity Securities.
|
On
June 13, 2018, the Company held its first closing (the “
First Closing
”) of a private offering (the “
Private
Offering
”) of up to 25,000,000 Units (“
Units
”), subject to increase to up to 30,000,000 Units, at
a price of $0.10 per Unit. Each consists of (a) one share of the Company’s common stock (“
Shares
”); and
(b) one five-year common stock purchase warrant (“
Warrants
”).
The
Warrants entitle the holder thereof to purchase one Share at an exercise price of $0.15 during the five (5) year period following
the closing of the Subscriber’s investment. The exercise price and number of Shares issuable upon exercise of the Warrants
will be subject to anti-dilution adjustment in the event of stock splits, stock dividends and similar recapitalization events.
Within ninety (90) days after the final closing of the Private Offering, the Company must file with the Securities and Exchange
Commission (the “
SEC
”) a registration statement under the Securities Act of 1933, as amended (the “
Securities
Act
”), covering the resale of the Shares included in the Units and issuable upon exercise of the Warrants. In the event
the Company fails to file the registration statement within such ninety (90) day period, the exercise price of the Warrants will
be automatically reduced from $0.15adjusted downward to $0.10. The Warrants will not be redeemable by the Company. The Warrants
will provide for a “
cashless
” exercise in the event that the Company does not have the above-referenced registration
statement declared effective by the SEC on or before the six-month anniversary of the final closing of the Private Offering.
At
the First Closing, the Company issued and sold an aggregate of 6,000,000 Units to four “
accredited investors
,”
as defined in Rule 501(a) under the Securities Act for cash proceeds of $600,000. In addition, at the First Closing, a $175,000
ninety (90) day convertible bridge promissory note (the “
Bridge Note
”) issued by the Company in May 2018 to
a single accredited investor in a private transaction, converted into 2,187,500 Units in accordance with its terms.
WestPark
Capital, Inc., a member of the Financial Industry Regulatory Authority, has been engaged as the Company’s exclusive placement
agent (the “
Placement Agent
”) for the Private Offering. The Placement Agent is being paid (a) a commission
equal to 10% of the aggregate offering price of Units sold in the Private Offering and issued upon conversion of the Bridge Note;
and (b) a non-accountable expense allowance equal to 3% of the aggregate offering price of Units sold in the Private Offering.
In addition, the Placement Agent will receive a seven-year warrant to purchase a number of Units equal to 10% of the total Units
sold in the Private Offering, with an exercise price of $0.10 per Unit. The Company has also paid the Placement Agent (a) a $15,0000
non-refundable retainer for agreeing to act as placement agent for the Private Offering; and (b) $10,000 for the Placement Agent’s
legal fees.
The
Units offered and sold in the Private Offering and the Bridge Note and the Units issued upon conversion of the Bridge Note, were
issued and sold pursuant to the exemption from registration afforded by Section 4(a)(2) of the Securities Act and Rule 506(b)
of Regulation D thereunder.
Item
9.01 Financial Statements and Exhibits
(d)
Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Dated:
June 19, 2018
|
SANSAL
WELLNESS HOLDINGS, INC.
|
|
|
|
|
By:
|
/s/
Alexander M. Salgado
|
|
|
Alexander
M. Salgado, Chief Executive Officer
|
Veritas Farms (QB) (USOTC:VFRM)
Historical Stock Chart
From Feb 2024 to Mar 2024
Veritas Farms (QB) (USOTC:VFRM)
Historical Stock Chart
From Mar 2023 to Mar 2024